Vice President

• Oversee disease area strategy development across all therapeutic areas for drug development to influence portfolio-level decisions.
• Partner with Drug Development Franchise Leads to ensure each disease assessment is grounded in a deep understanding of emerging science, competitive environment, and evolution of the landscape over the 10+ year horizon.
• Build capability for enabling development of disease plans that are robust, actionable, and competitively differentiated, implementing a consistent approach across teams.
• Lead drug development portfolio prioritization process, ensuring transparency and rigor in decisions.
• Drive alignment with key stakeholders including Enterprise Strategy and Research, Development and Commercial teams (RDC) to integrate disease strategies into therapeutic area strategies consistent with enterprise goals.
• Serve as a thought leader and strategic advisor to senior leadership on portfolio and investment decisions.

Vice President, Drug Development Portfolio Strategy

Vice President, Macroeconomic Model Development, Scenario Expansion

AVP, Technical Manager

Vice President, GCO Americas

Vice President, GCO Americas

Vice President, Global Brand Leader – Fabry Disease